T1	Participants 324 341	patients with CHF
T2	Participants 141 191	patients with advanced chronic heart failure (CHF)
T3	Participants 374 537	23 patients in NYHA class II and III (20 men, three women, mean age 59+/-9 years) with stable CHF secondary to ischaemic heart disease [ejection fraction 37+/-7%],
